Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018)
Akebia Therapeutics (AKBA) posted quarterly Current Taxes of $987000.0 for Q1 2018, little changed quarter-over-quarter from $987000.0 in Q4 2017.
Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Current Taxes for 2 consecutive years, with $987000.0 the latest figure, recorded in Q1 2018.
- In Q1 2018, Current Taxes changed N/A year-over-year to $987000.0; the TTM figure through Mar 2018 stood at $987000.0 (changed N/A YoY), while the FY2017 annual figure was $987000.0, changed N/A from the prior year.
- Current Taxes steadied at $987000.0 in Q1 2018 per AKBA's latest filing, from $987000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $987000.0 in Q4 2017 and bottomed at $987000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 46.00 Mn |
| 10 | Akebia Therapeutics | 245.42 Mn | 89.87 Mn | 38.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 987,000.00 |
| Dec 31, 2017 | 987,000.00 |